2C-T-19
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a possible psychedelic drug of the phenethylamine and 2C families.[1]
Other names4-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-butylthiophenethylamine; 2C-T-Bu
Routes of
administrationUnknown[1]
administrationUnknown[1]
ATC code
- None
Duration of actionUnknown[1]
| |
 | |
| Clinical data | |
|---|---|
| Other names | 4-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-butylthiophenethylamine; 2C-T-Bu |
| Routes of administration | Unknown[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.[1]
Society and culture
Legal status
Canada
As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.[2]
United States
In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.